Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: A systematic review

Diabetic Medicine

Volumn 27, Issue 7, 2010, Pages 812-822

  Speight, J ^a   Reaney, M D ^a   Woodcock, A J ^b   Smith, R M ^c   Shaw, J A M ^d  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

islet transplantation; pancreas transplantation; patient reported outcomes; quality of life; satisfaction

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DEPRESSION; HEALTH STATUS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PANCREAS TRANSPLANTATION; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT SATISFACTION; POSTOPERATIVE PAIN; QUALITY OF LIFE; SELF REPORT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; QUALITY OF LIFE; SELF REPORT; TREATMENT OUTCOME;

EID: 77954304378     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03029.x     Document Type: Article

References (32)

1. Griva K, Newman S. Transplantation. In : Ayers S, Baum A, McManus C, Newman S, Wallston K, Weinman J et al. eds. Cambridge Handbook of Psychology, Health and Medicine. 2nd edn.
2. Piper M, Seidenfeld J, Aronson N. Islet Transplantation in Patients with Type 1 Diabetes Mellitus. Evidence Report/Technology Assessment. No. 98.
3. Couzin J. Islet transplants face test of time. Science 2004 306 : 34 37.
4. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DER. Pancreas and islet transplantation for patients with diabetes. Diabetes Care 2000 23 : 112 116. (Pubitemid 30022905)
5. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a clucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 238.
6. Ryan EA, Breay WP, Senior PA, Bigam D, Alfadhli E, Kneteman NM et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069. (Pubitemid 40911269)
7. Leitão, Cure P, Tharavanij T, Baidal DA, Alejandro R. Current challenges in islet transplantation. Curr Diab Rep 2008 8 : 324 331.
8. Robertson RP. 2005 Update: impact of pancreas and islet transplants on acute and chronic complications of diabetes. Curr Opin Organ Transplant 2005 10 : 176 180.
9. National Institute for Clinical Excellence (NICE) 2008. Interventional Procedure Consultation Document: Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. Available at http://guidance.nice. org.uk/IPG257/Guidance/pdf/English Last accessed 18 May 2010.
10. Barshes NR, Vanatta JM, Mote A, Lee TC, Schock AP, Balkrishnan R et al. Health-related quality of life after pancreatic islet transplantation: a longitudinal study. Transplantation 2005 79 : 1727 1730.
11. Benhamou PY, Milliat-Guittard L, Wojtusciszyn A, Kessler L, Toso C, Baertschiger R et al. Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials. Diabet Med 2009 26 : 617 621.
12. Humar A, Ramcharan T, Kandaswamy R, Matas A, Gruessner RW, Gruessner AC et al. Pancreas after kidney transplants. Am J Surg 2001 182 : 155 161.
13. Illner WD, Schneeberger H, Hofmann G, Piehlmeier W, Mojto J, Scheuer R et al. Duct occlusion-induced vascularized islet grafts are not associated with progressive long-term dysfunction. Transplant Proc 1995 27 : 1342 1346.
14. Rodriguez Rilo HL, Ahmad SA, D'Alessio D, Iwanaga Y, Kim J, Choe KA et al. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg 2003 7 : 978 989.
15. Cure P, Pileggi A, Froud T, Messinger S, Faradji RN, Baidal DA et al. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation 2008 85 : 801 812.
16. Poggioli R, Faradji RN, Ponte G, Betancourt A, Messinger S, Baidal DA et al. Quality of life after islet transplantation. Am J Transplant 2006 6 : 371 378.
17. Tharavanij T, Betancourt A, Messinger S, Cure P, Leitao CB, Baidal DA et al. Improved long-term health-related quality of life after islet transplantation. Transplantation 2008 86 : 1161 1167.
18. Hafiz MM, Faradji R, Froud T, Pileggi A, Baidal DA, Cure P et al. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation 2005 80 : 1718 1728.
19. Sutherland DER, Gruessner RWG, Dunn DL, Matas AJ, Humar A, Kandaswamy R et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001 233 : 463 501.
20. Terán-Escandón D, Terán-Ortiz L, Ormsby-Jenkins C, Evia-Viscarra ML, White DJG, Valdés-González-Salas R. Psychosocial aspects of xenotransplantation: survey in adolescent recipients of porcine islet cells. Transplant Proc 2005 37 : 521 524.
21. Toso C, Shapiro AMJ, Bowker S, Dinyari P, Paty B, Ryan EA et al. Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome. Transplantation 2007 84 : 664 666.
22. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993 29 : 321.
23. The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988 11 : 725 732.
24. Cox D, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987 10 : 617.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 : 361 370.
26. Ware JEJ, Sherbourne CDT. The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care 1992 30 : 473 483.
27. Radosenick DM, Wetzler H, Wilson SM. Health Status Questionnaire (HSQ) 2.0 Scoring Comparisons and Reference Data.
28. Feeny D, Torrance G, Furlong W. Health utilities index. In : Spiker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials.
29. Schlag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 1984 2 : 187 193.
30. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975 1 : 277 299.
31. Ziegelman JP, Griva K, Hankins M, Harrison M, Davenport A, Thompson D et al. The Transplant Effects Questionnaire (TxEQ): the development of a questionnaire for assessing the multidimensional outcome of organ transplantation - example of end stage renal disease (ESRD). Br J Health Psychol 2002 7 : 393 408.
32. Speight J, Woodcock A, Reaney M, Amiel S, Johnson P, Parrott N et al. Expectations and experiences of transplant: a qualitative study of people with Type 1 diabetes undergoing pancreatic islet transplantation. Diabet Med 2009 24 : S189.